Baker Brothers Life Sciences LP, Director, 10% Owner at Kodiak Sciences Inc. (KOD), bought 801,063 shares at $53.73 ($43.6M) on 2022-02-16, disclosed to the SEC on 2022-02-17.
Open-market purchase of $43.6M KOD by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.16 | 441 | $24K | 0.1% |
| 2 | $54.16 | 5,359 | $290K | 0.7% |
| 3 | $54.16 | 5,359 | $290K | 0.7% |
| 4 | $53.73 | 1,961 | $105K | 0.2% |
| 5 | $53.73 | 1,961 | $105K | 0.2% |
| 6 | $53.73 | 23,804 |
| $1.3M |
| 2.9% |
| 7 | $53.73 | 23,804 | $1.3M | 2.9% |
| 8 | $54.26 | 64,119 | $3.5M | 8.0% |
| 9 | $54.26 | 5,281 | $287K | 0.7% |
| 10 | $54.26 | 5,281 | $287K | 0.7% |
| 11 | $54.26 | 64,119 | $3.5M | 8.0% |
| 12 | $53.82 | 426 | $23K | 0.1% |
| 13 | $53.82 | 5,174 | $278K | 0.6% |
| 14 | $53.82 | 5,174 | $278K | 0.6% |
| 15 | $54.57 | 22,403 | $1.2M | 2.8% |
| 16 | $54.57 | 22,403 | $1.2M | 2.8% |
| 17 | $54.57 | 271,997 | $14.8M | 34.0% |
| 18 | $54.57 | 271,997 | $14.8M | 34.0% |
| Total | $54.45 avg | 801,063 | $43.6M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |